Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$44.19 USD

44.19
648,432

-0.01 (-0.02%)

Updated May 31, 2024 04:00 PM ET

After-Market: $44.18 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for QDEL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

QuidelOrtho Corporation [QDEL]

Reports for Purchase

Showing records 101 - 120 ( 185 total )

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 101

02/09/2015

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of Feb 9

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 102

02/05/2015

Company Report

Pages: 9

4Q14 Preview - Expecting In-Line Revs Post Preannouncement - EPS Probably Shaping Up Better on

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 103

12/14/2014

Industry Report

Pages: 5

LIFE SCIENCES AND HEALTH CARE

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 104

10/22/2014

Company Report

Pages: 12

3Q14 Recap - Grant Revs Drive Top-line Beat - Good Flu Sales Offset By Lackluster Other Products - GMs Better - EPS Relatively Ok - Maintain N

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 105

10/14/2014

Company Report

Pages: 11

3Q14 Preview - Expecting Slightly Better Sales and In-line EPS Loss

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 106

07/23/2014

Company Report

Pages: 12

Upgrading to NEUTRAL on More Reasonable Expectations, New Product Breadth & Favorable Trading Pattern; 2Q14 Top Line Ok - Mix Impacts EPS - PT to $20

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 107

07/18/2014

Industry Report

Pages: 6

LIFE SCIENCES AND HEALTH CARE-The Week Ahead in Life Sciences - Upcoming Events for the Week of July 21

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 108

07/18/2014

Company Report

Pages: 8

2Q14 Looks Doable If Strep Normalizes - Meaningful New Sofia Data Unlikely Given Seasonally Slow Period - Maintain UNDERPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 109

04/23/2014

Company Report

Pages: 12

1Q14 Miss Driven By Light Flu Activity - Sofia Sales Ok, But

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 110

04/21/2014

Industry Report

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 111

04/21/2014

Industry Report

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 112

04/16/2014

Company Report

Pages: 9

1Q14 Financial Preview - Expecting Roughly In-line Results - Anticipating Sofia to Pad Flu Sales

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 113

02/12/2014

Company Report

Pages: 10

Full 4Q Recap - Flu Sales Better - Sofia Fine - EPS Softer and 2014 Leverage Story Lacking

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 114

02/09/2014

Daily Note

Pages: 6

LIFE SCIENCES AND HEALTH CARE

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 115

02/06/2014

Company Report

Pages: 9

Expecting In-Line 4Q13 Results

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 116

01/06/2014

Daily Note

Pages: 15

Week 52 Flu Update - Activity Continues to Rise - Season Shaping Up Similar to 2010-2011, An Above-Average Season

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 117

01/06/2014

Daily Note

Pages: 15

Week 52 Flu Update - Activity Continues to Rise - Season Shaping Up Similar to 2010-2011, An Above-Average Season - Reaffirm UNDERPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 118

12/30/2013

Daily Note

Pages: 15

Week 51 Flu Update - Flu Activity Accelerates Strongly In Last Two Weeks - Check Suggests Timing Too Late to Drive 4Q13 Upside - Reaffirm UP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 119

12/30/2013

Daily Note

Pages: 15

Week 51 Flu Update - Flu Activity Accelerates Strongly In Last Two Weeks - Check Suggests Timing Too Late to Drive 4Q13 Upside - Reaffirm UP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 120

10/24/2013

Company Report

Pages: 10

3Q13 Results Soft - Cont''d Strep A Weakness & Lower Pregnancy Drives Miss - Flu Sales Better - Sofia Comments Stay Bullish - Maintaining UP

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party